| Literature DB >> 30949156 |
Xinlong He1,2,3,4, Shuang Li1, Yi Yin1, Jiahui Xu1, Weijuan Gong1, Guocai Li1, Li Qian1, Yinyan Yin1, Xiaoqin He2, Tingting Guo1, Yuzheng Huang2, Feng Lu1,2,3,5, Jun Cao2,6,7.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) has received increasing attention in recent years. However, the characteristics and relevant mechanisms of biofilm formation in oxacillin-sensitive MRSA (OS-MRSA) are poorly understood. This study was designed to characterize biofilm formation in OS-MRSA BWSA15 in response to ceftazidime (TZ) by comparing the methicillin-sensitive S. aureus (MSSA) strain BWSA23 and the oxacillin-resistant MRSA (OR-MRSA) strain BWSA11. The biofilms and biofilm-forming cells were observed by electron microscopy. Biofilms grown on microtiter plates were chemically decomposed and analyzed by Fourier transform infrared spectroscopy. The transcriptional regulation of genes associated with methicillin resistance, surface adhesion, fatty acid biosynthesis, and global regulation (sigma B) was investigated. A significant increase in biofilm formation ability (10.21-fold) and aggregation ability (2.56-fold) was observed in BWSA15 upon the treatment with TZ (16 μg/ml). The TZ-induced biofilm formation in BWSA15 was characterized by a disappearance of polysaccharide-like extracellular substances and an appearance of a large number of intercellular MVs from extracellular matrix. Few MVs were identified in the biofilms formed by BWSA11 and BWSA23. There was a significant upregulation of mecA, sigB, and fatty acid biosynthesis-associated genes and downregulation of icaA, icaD, clfA, clfB, and fnaA in BWSA15 upon the treatment with TZ. The formation of intracellular junctions of MVs in the biofilms of BWSA15 was mediated by a significant increase in the proportion of proteins as well as by an increase in the proportion of non-ionized carboxyl groups in fatty acids. This study demonstrated that beta-lactam antibiotics can induce biofilm formation in OS-MRSA, and the biofilm induction in OS-MRSA can mainly be attributed to exposed MVs with increased hydrophobicity rather than polysaccharide intercellular adhesins, cell wall-anchored surface proteins, and extracellular DNA.Entities:
Keywords: MRSA; antibiotic resistance; biofilm; membrane vesicle; methicillin-resistant Staphylococcus aureus
Year: 2019 PMID: 30949156 PMCID: PMC6438146 DOI: 10.3389/fmicb.2019.00571
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Sequences of oligonucleotide primers used for real-time RT-PCR.
| Gene | Function | Primer direction: sequence | Reference |
|---|---|---|---|
| Housekeeping gene | F: CGGTCCAGACTCCTACGGGAGGCAGCA | ||
| R: GCGTGGACTACCAGGGTATCTAATCC | |||
| Penicillin-binding protein 2A | F: GCAATCGCTAAAGAACTAAG | ||
| R: GGGACCAACATAACCTAATA | |||
| Clumping factor A | F: ATTGGCGTGGCTTCAGTGCT | ||
| R: CGTTTCTTCCGTAGTTGCATTTG | |||
| Clumping factor B | F: ACATCAGTAATAGTAGGGGCAAC | ||
| R: TTCGCACTGTTTGTGTTTGCAC | |||
| Fibronectin-binding protein A | F:CATAAATTGGGAGCAGCATCA | ||
| R: ATCAGCAGCTGAATTCCCATT | |||
| Fibronectin-binding protein B | F: GTAACAGCTAATGGTCGAATTGATACT | ||
| R: CAAGTTCGATAGGAGTACTATGTTC | |||
| PIA/PNAG biosynthesis | F: ACACTTGCTGGCGCAGTCAA | ||
| R: TCTGGAACCAACATCCAACA | |||
| PIA/PNAG biosynthesis | F: ATGGTCAAGCCCAGACAGAG | ||
| R: AGTATTTTCAATGTTTAAAGCAA | |||
| PIA/PNAG biosynthesis | F: AGAATCGTGAAGTATAGAAAATT | ||
| R: TCTAATCTTTTTCATGGAATCCGT | |||
| PIA/PNAG biosynthesis | F: ATGGGACGGATTCCATGAAAAAGA | ||
| R: TAATAAGCATTAATGTTCAATT | |||
| Fatty acid biosynthesis | F: TTGACGCATAGTTCGGCATT | ||
| R: ACTGCAGCCATGCTTCCTACA | |||
| Fatty acid biosynthesis | F: TTCTGGTATCGGTGGTATGGA | ||
| R: CTTGCCCAGTTGCCATATCA | |||
| Fatty acid biosynthesis | F: GTTGCCGATGCTGATGAAGT | ||
| R: TCATCCCACTCTTGTTCTTTCA | |||
| Fatty acid biosynthesis | F: GATAACCGCACCTGCACCAT | ||
| R: TGGATCAACTTGCAGCATGTT | |||
| Fatty acid biosynthesis | F: GAAGACTTACGCGGACGCTT | ||
| R: TGCTACCACCTTCTGGCATTA | |||
| Sigma factor B | F: TGAAGATGCCAAGATTGCAGT | ||
| R: CTAGGCCACCTTCGCGTAA | |||
Minimum inhibitory concentration (μg/ml) of antibiotics against S. aureus strains.
| Antibiotic (class) | ATCC 29213 | BWSA11 | BWSA15 | BWSA23 |
|---|---|---|---|---|
| TZ (beta-lactam) | 16 (I) | >512 (R) | 32 (R) | 16 (I) |
| EM (macrolide) | 0.5 (S) | >512 (R) | 1 (I) | 0.25 (S) |
| GM (aminoglycoside) | 0.5 (S) | >512 (R) | 1 (S) | 0.5 (S) |
| LE (fluoroquinolone) | <0.25 (S) | 128 (R) | 0.5 (S) | <0.25 (S) |
| OX (beta-lactam) | 0.25 (S) | >512 (R) | 2 (S) | 2 (S) |
| TC (tetracycline) | 0.5 (S) | 128 (R) | 2 (S) | 2 (S) |
| VA (glycopeptide) | 0.5 (S) | 1 (S) | 0.5 (S) | 1 (S) |
FIGURE 1Relative biofilm formation index of Staphylococcus aureus. TZ, in the presence of ceftazidime (TZ) (16 μg/ml). Error bars represent the standard deviations (n = 3). ∗P < 0.05 (Student’s t-test) indicate significant differences compared to BWSA15.
Percent reduction in the biomass of S. aureus biofilms treated with proteinase K (100 μg/ml), NaIO4 (10 mg/ ml), or DNase I (1000 U/ml).
| Strain | Proteinase K | NaIO4 | DNaseI |
|---|---|---|---|
| BWSA15 | 69.87 ± 7.90 | 17.73 ± 1.21 | 4.11 ± 0.83 |
| BWSA15TZ | 80.84 ± 5.53 | 5.47 ± 0.95 | 9.47 ± 1.76 |
| BWSA11 | 81.88 ± 5.85 | 2.02 ± 0.66 | 7.03 ± 0.91 |
| BWSA23 | 6.68 ± 0.95 | 83.16 ± 5.47 | 5.55 ± 0.64 |
FIGURE 2Surface adhesion of S. aureus. TZ, in the presence of TZ (16 μg/ml). Error bars represent the standard deviations (n = 3). ∗P < 0.05 (Student’s t-test) indicate significant differences compared to BWSA15.
FIGURE 3Intercellular aggregation of S. aureus. TZ, in the presence of TZ (16 μg/ml). Error bars represent the standard deviations (n = 3). ∗P < 0.05 (Student’s t-test) indicate significant differences compared to BWSA15.
FIGURE 4Scanning electron microscopy images of MVs formed by S. aureus BWSA15 (A), S. aureus BWSA15 in the presence of TZ (B), S. aureus BWSA11 (C), and S. aureus BWSA23 (D). TZ, biofilm formed under TZ stress (16 μg/ml); white arrows indicate MVs; black arrows indicate mucous-like extracellular substances.
FIGURE 5Secretion and production of MVs by S. aureus. TEM images of thin sections of biofilm-forming S. aureus BWSA15 in the presence of TZ (A,B) and S. aureus BWSA23 (C) showing the extracellular MVs (arrow 1) and intracellular MV-like structures (arrow 2–5). PM, plasma membrane.
FIGURE 6FTIR spectra of biofilms formed by BWSA15, BWSA11, and BWSA23. TZ, in the presence of TZ (16 μg/ml).
Main functional group assignments of infrared bands identified in S. aureus biofilms.
| Frequency (cm-1) | Assignment | Reference |
|---|---|---|
| 3410 | Symmetric and asymmetric stretching of –OH bond in water | |
| 2970 | C–H asymmetric and symmetric stretching modes of methyl in fatty acids | |
| 2940 | C–H asymmetric and symmetric stretching modes of methylene in fatty acids | |
| 1650 | C = O stretching in amide I from proteins | |
| 1550 | N–H bending in amide II from proteins | |
| 1450 | C–H deformation of methylene in fatty acids | |
| 1400 | Symmetric stretching vibration of COO- | |
| 1250 | Asymmetric stretching vibration of PO2- | |
| 1080 | C–O and C–O–C ring vibrations in polysaccharides | |
FIGURE 7Fold change in the transcriptional expression of genes associated with (A) the biosynthesis of the PBP2a protein (mecA), (B) the surface adhesins including the surface proteins (clfA, clfB, and fnbA) and the exopolysaccharides PIA/PNAG (icaA and icaD), (C) the membrane fatty acids (fabD, fabF, fabG, and fabH), and (D) sigma factor B (sigB) in S. aureus. ND, not detectable. TZ, in the presence of TZ (16 μg/ml). Error bars represent the standard deviations (n = 3). ∗P < 0.05 (Student’s t-test) indicate significant differences compared to BWSA15.
FIGURE 8Schematic representation of the cross section of the MV precursor, septum, and mesosome in S. aureus. The MV precursor is characterized by fusion between the MV-like structure and the PM (A); the septum is characterized by cell wall extension along with a non-coiled invagination in the PM (B); and the mesosome is characterized by cell wall infiltration in a folded and coiled invagination in the PM (C). PM, plasma membrane.